Search Results for: Centeno

Review of clinic exposé film From Jail Cell to Stem Cell

Erin-Elizabeth

Stem cell clinics and suppliers have been getting into the business of making promotional films to generate more revenue, but now there’s something very different in the cinematic stem cell arena called From Jail Cell to Stem Cell by filmmaker Doug Orchard. It is at its heart an exposé film about some in my view particularly concerning stem […]

Review of clinic exposé film From Jail Cell to Stem Cell Read More »

More Liveyon links to exosome Awakening film include potential relative

Awakening-film-marketing-screenshot

A new film-commercial entitled Awakening pitches unproven exosomes and has already been possibly tied to the troubled stem cell supplier firm Liveyon, but now it seems that the links go far deeper including a possible relative of Liveyon leader John Kosolcharoen. Even so, Kosolcharoen (pictured with another Liveyon leader Alan Gaveck below in a web

More Liveyon links to exosome Awakening film include potential relative Read More »

Mystery of wild sci-fi film ad for unproven exosomes: Liveyon?

awakening-exosome-film-ad

What’s Liveyon up to these days? A new, somewhat mysterious short film that serves as an advertisement for unproven exosomes has some of us scratching our heads. It seems to point to Liveyon. Can you guys as readers of The Niche help solve the puzzle of who’s behind this wild “cinematic commercial” and what the

Mystery of wild sci-fi film ad for unproven exosomes: Liveyon? Read More »

Chiropractors and their state boards should stop risky stem cell injections

chiropractor-stem-cells

There are gray areas within the larger stem cell sphere or as I called it in a recent paper “the stem cell ecosystem“, but chiropractors doing stem cell transplants is not one of them. This is unethical and risky on many levels, but the number of chiropractors selling stem cells is increasing rapidly nonetheless. Chiropractors

Chiropractors and their state boards should stop risky stem cell injections Read More »

Stem cell therapy reviews: knees, lung, autism, & Regenexx

stem-cell-therapy-reviews

Who decides whether a stem cell therapy is “good” or “bad”, and should that kind of a judgment be more focused on direct patient perspectives such as their stem cell therapy reviews as consumers or based on biomedical science? Both? I’ve written before about how stem cell patients are increasingly thinking of themselves as consumers

Stem cell therapy reviews: knees, lung, autism, & Regenexx Read More »

When the fat stem cells hit the fire, will clinics sued by FDA opt to stop soon?

when-the-fat-hits-the-fire-stem-cells

Will the adipose stem cell clinic firms facing permanent injunction suits by the FDA — U.S. Stem Cell Inc. (USRM) and California Stem Cell Treatment Center (CSCTC)/Cell Surgical Network (CSN) — cool it in the sense of voluntarily shutting down their commercial fat stem cell injections of customers soon pending the outcomes of the suits?

When the fat stem cells hit the fire, will clinics sued by FDA opt to stop soon? Read More »

Internecine conflicts among direct-to-consumer stem cell firms

Regenexx-blog

Stem cell clinics marketing non-FDA approved therapies directly to consumers have been in various tense situations at times with the FDA or academics over the years, but more recently these stem cell clinic-related firms also appear in conflict with each other sometimes. The most notable recent example of conflict involves Dr. Christopher Centeno of Regenexx

Internecine conflicts among direct-to-consumer stem cell firms Read More »

Do for-profit stem cell studies have inherent potential biases?

There’s been an interesting and diverse discussion going on here on this blog lately related to some stem cell translational things including a stem cell clinic operating in Sacramento (see 50+ comments on that post) and then more recently on a new paper from the Centeno clinic. .@pknoepfler Did most (or all) participants in this study pay

Do for-profit stem cell studies have inherent potential biases? Read More »

FDA meeting on stem cell regs: mostly who’s who of anti-regulation forces

FDAADF

The FDA in the past year or so has issued draft guidances on regulation of stem cells that would, if finalized, make it crystal clear that what many American stem cell clinics are selling are unapproved drugs. That would be a good thing for patients who are often being put at risk by many of

FDA meeting on stem cell regs: mostly who’s who of anti-regulation forces Read More »